Breakthrough T1D (formerly JDRF): Translational Strategies to Define, Enhance, and Monitor Vascularization for Durable Islet Replacement Therapies – Competitive LOI’s

To support translational research that advances the clinical application of vascularization- and engraftment-focused strategies for islet replacement therapy in type 1 diabetes (T1D).

Funding: up to $900K over 3 years

https://www.breakthrought1d.org/wp-content/uploads/2025/12/RFA_Vascularization_Call-Document.pdf

https://www.breakthrought1d.org/explore-research/funding-opportunities/